Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 916

Results For "US"

10202 News Found

Tata Medical develops OmiSure to detect Omicron
Medical Device | January 05, 2022

Tata Medical develops OmiSure to detect Omicron

The test kit is compatible with all standard Real-Time PCR machines with a test run time of 85 minutes. The result turnaround time, including sample collection and RNA extraction, is 130 minutes


Dr Reddy’s molnupiravir priced at Rs 1,400 for a course
News | January 04, 2022

Dr Reddy’s molnupiravir priced at Rs 1,400 for a course

Molflu is expected to be available from early next week in pharmacies throughout the country with a particular focus on states with a high caseload of Covid-19.


Dassault Systèmes to showcase the Virtual Twin Experience of the human body at CES 2022
Digitisation | January 04, 2022

Dassault Systèmes to showcase the Virtual Twin Experience of the human body at CES 2022

The virtual world makes it possible to visualize, test, understand and predict what cannot be seen, before a patient is treated


Amyris and ImmunityBio JV for next gen Covid-19 RNA vaccine
Biotech | January 04, 2022

Amyris and ImmunityBio JV for next gen Covid-19 RNA vaccine

Upon completion of successful human trials and regulatory approval, the joint venture's goal is to start delivering the second-generation vaccine in 2022 as soon as is practically possible


Kyverna Therapeutics announces licence agreement with NIH
Biotech | January 04, 2022

Kyverna Therapeutics announces licence agreement with NIH

This next-generation CAR T construct was designed to improve the tolerability profile of conventional CD19 CAR Ts and developed in the laboratory of James N. Kochenderfer, M.D., at the National Cancer Institute, part of the NIH, the same laboratory that discovered axicabtagene ciloleucel


Combination of Covishield-Covaxin more effective: AIG hospital study
News | January 04, 2022

Combination of Covishield-Covaxin more effective: AIG hospital study

The first pilot study from India analyzing Covaxin-Covishield mixed doses


Domestic and emerging markets will drive pharma growth: ICRA
News | January 04, 2022

Domestic and emerging markets will drive pharma growth: ICRA

Healthy growth in domestic and emerging markets is expected to support revenue growth in the next few quarters


Yokogawa invests in glycan production company GlyTech
Biotech | January 04, 2022

Yokogawa invests in glycan production company GlyTech

Partnering to build biosynthesis processes and a pharmaceutical production platform


Novavax submits data to U.S. FDA for Covid-19 EUA
Biotech | January 03, 2022

Novavax submits data to U.S. FDA for Covid-19 EUA

Emergency Use Authorisation application request to be submitted following one month required by FDA EUA guidance


U.S. FDA grants EUA for Pfizer-BioNTech booster for 12 years and older
News | January 03, 2022

U.S. FDA grants EUA for Pfizer-BioNTech booster for 12 years and older

First emergency use authorization in the United States for a Covid-19 vaccine booster in adolescents 12 through 15 years of age